logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
mFluor™ Violet 510 Anti-human CD71 Antibody
OKT-9
The OKT-9 monoclonal antibody binds with human CD71, a 95 kD glycoprotein commonly expressed on the surface of reticulcytes, proliferating cells, reticulocytes and erythroid precursors. In many organisms, CD71 acts to positively regulate B cell proliferation, is a positive regulator of bone resorption and is an enhancer of T cell proliferation. From a research standpoint, it is of biological interest due to its association with vital macromolecules/ligands like Transferrin. CD71 is a fairly uncommon antibody target, with a little more than 4300 publications in the last decade. Even still, CD71 is frequently used in flow cytometry applications as a phenotypic marker for differentiation of cell types, especially in the study of immunology. This antibody was purified through affinity chromatography and conjugated to mFluor™ Violet 510 (ex/em = 412/505 nm). It is compatible with the 405 nm laser and 525/50 nm bandpass filter (for example, as in the Miltenyi Biotec MACSQuant VYB).
product image
product image
CatalogSize
Price
Quantity
10713110100 tests
Price
10713111500 tests
Price
 
Antibody properties

Other namesT9; Transferrin receptor; TFRC
CloneOKT-9
Hostmouse
Isotypemouse igg1, κ
Reactivityhuman
ApplicationFlow Cytometry (FACS); Fluorescence Imaging
Spectral properties

Absorbance (nm)410
Correction factor (260 nm)0.464
Correction factor (280 nm)0.366
Extinction coefficient (cm -1 M -1)
25000
1
Excitation (nm)412
Emission (nm)505
Quantum yield
0.86
1
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on September 24, 2025